Emerging nano-based strategies against drug resistance in tumor chemotherapy

L Cao, Y Zhu, W Wang, G Wang, S Zhang… - … in bioengineering and …, 2021 - frontiersin.org
Drug resistance is the most significant causes of cancer chemotherapy failure. Various
mechanisms of drug resistance include tumor heterogeneity, tumor microenvironment …

Application of stimuli responsive nanocomposites in drug delivery and theranostics to counter cancer proliferation and drug resistance

N Khanna, T Chatterji, S Singh, S Pandey - Journal of Drug Delivery …, 2023 - Elsevier
Ingenious nanomedical researches have ameliorated outcomes in cancer theranostics.
Though limitations like non specific distribution generating low signal to noise ratio in …

Polymeric dendrimers as nanocarrier vectors for neurotheranostics

H Li, S Zha, H Li, H Liu, KL Wong, AH All - Small, 2022 - Wiley Online Library
Dendrimers are polymers with well‐defined 3D branched structures that are vastly utilized in
various neurotheranostics and biomedical applications, particularly as nanocarrier vectors …

Recent progress and advances of multi-stimuli-responsive dendrimers in drug delivery for cancer treatment

NTT Le, TNQ Nguyen, VD Cao, DT Hoang, VC Ngo… - Pharmaceutics, 2019 - mdpi.com
Despite the fact that nanocarriers as drug delivery systems overcome the limitation of
chemotherapy, the leakage of encapsulated drugs during the delivery process to the target …

Self-assembling ferritin-dendrimer nanoparticles for targeted delivery of nucleic acids to myeloid leukemia cells

F Palombarini, S Masciarelli, A Incocciati… - Journal of …, 2021 - Springer
Background In recent years, the use of ferritins as nano-vehicles for drug delivery is taking
center stage. Compared to other similar nanocarriers, Archaeoglobus fulgidus ferritin is …

Drug delivery of siRNA therapeutics

G Lamberti, AA Barba - Pharmaceutics, 2020 - mdpi.com
Small interfering RNA (siRNA) is a class of nucleic acid-based drugs (NABDs) able to block
gene expression by interaction with mRNA before its translation. Small interfering RNAs …

Clinical and Translational Opportunities of Nanocarriers Containing RNAi for the Management of Triple‐Negative Breast Cancer

S Sharma, R Pradhan, D Lee, M Sharma… - Advanced …, 2024 - Wiley Online Library
Triple‐negative breast cancer develops from malignant cells within the interior lining of milk
ducts or, less frequently, in the stromal tissues and accounts for≈ 15% of all breast cancers …

Cationic dendrimers for siRNA delivery: an overview of methods for in vitro/in vivo characterization

E Laurini, S Aulic, D Marson, M Fermeglia… - Design and Delivery of …, 2021 - Springer
This chapter reviews the different techniques for analyzing the chemical-physical properties,
transfection efficiency, cytotoxicity, and stability of covalent cationic dendrimers (CCDs) and …

Development and characterization of temozolomide-PAMAM-siRNA dendriplexes for the effective management of glioblastoma multiforme

T Gupta, RK Sahoo, AK Yadav, U Gupta - Journal of Nanoparticle …, 2024 - Springer
This study was aimed to develop and evaluate the TMZ-PAMAM-siRNA [temozolomide-
polyamidoamine dendimer-siRNA] dendriplexes for the effective treatment of glioblastoma …

Evolution from covalent to self-assembled PAMAM-based dendrimers as nanovectors for siRNA delivery in cancer by coupled in silico-experimental studies. Part II …

E Laurini, D Marson, S Aulic, M Fermeglia, S Pricl - Pharmaceutics, 2019 - mdpi.com
In part I of this review, the authors showed how poly (amidoamine)(PAMAM)-based
dendrimers can be considered as promising delivering platforms for siRNA therapeutics …